Linda Harper

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

Maurizio Fava, David Mischoulon, Dan V. Iosifescu et al. · Psychotherapy and Psychosomatics · 2012 · 140 citations

A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder

Timothy E. Wilens, Brigitte Robertson, Vanja Sikirica et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2015 · 61 citations

Adhd, Psychiatry, Medicine +8

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder

Paula L. Jacobsen, Linda Harper, Lambros Chrones et al. · International Clinical Psychopharmacology · 2015 · 29 citations · Full text

Laboratory Values, Psychiatry, Psychotropic Medication +13

Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension

Thomas D. Giles, George L. Bakris, Suzanne Oparil et al. · Journal of the American Society of Hypertension · 2015 · 15 citations · Full text

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +18

P2‐377: A phase 2, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL‐108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment

Donald E. Schmechel, Gary Gerard, Nick G. Vatakis et al. · Alzheimer s & Dementia · 2008 · 13 citations

Brain Function, Neurochemical Biomarkers, Synaptic Signaling +28